Cytokine release syndrome as a consequence of check point inhibitors nivolimumab and iplimumab

Authors : Amrita Shah, Pradeep Rangappa, Ipe Jacob, Karthik Rao, Neelesh Reddy

DOI : 10.18231/j.ijpo.2022.096

Volume : 9

Issue : 4

Year : 2022

Page No : 392-394


 


Citation Data


Related Articles

Visual outcome in patients with traumatic optic neuropathy

G Ravi Babu, B Manjula, M Sudheer Kumar

Age estimation from eruption of permanent teeth in school children

Avinash H.Waghmode, Pravir Bodkha, Prafulla Pawar

Slow expansion in orthodontics -A review article

Merry, Insha Rasool, Sanjay Mittal, Isha Aggarwal, Tanzin Palkit

JAK inhibitors: Evolving therapies in rheumatoid arthritis

Shiva Shankar Jha

Study on the need to implement mentorship for the emotional development among medical students

Ramidha VP

Assessment on risk of developing nomophobia among adolescents in selected PU colleges

Ashmita Shrestha, R Rajesh, Mayuri Kesavan

Ameloblastoma with granular cell pattern - A bizarre presentation

Jesmith Elsa Jacob, Asish Rajasekharan, Tinky Bose C, Ramesh .S, Sunu Ramachandran, Akhilanand Chaur

COVID-19 vaccination status and treatment outcome: An observational study in a dedicated COVID Hospital of North East India

Bidhan Goswami, Biswajit Sutradhar, Shauli Sengupta, Himadri Bhattacharjya*, Bhaskar Bhattacharjee

A prospective analysis of the causes and characteristics of uveitis patients in a private practice set up in an urban south Indian population

Vijayan. S, Manoj Vasudevan